U4133

URB597

≥98% (HPLC), fatty acid amide hydrolase (FAAH) inhibitor, powder

• Sinónimos: Cyclohexylcarbamic acid 3´-carbamoyl-biphenyl-3-yl ester
• Fórmula empírica (notación de Hill): C₂₀H₂₂N₂O₃
• Número CAS: 546141-08-6
• Peso molecular: 338.40
• UNSPSC Code: 12352200
• PubChem Substance ID: 329827629
• NACRES: NA.77
• MDL number: MFCD05863934
• Assay: ≥98% (HPLC)
• Form: powder

Propiedades

• Nombre del producto: URB597, ≥98% (HPLC), powder
• description: Drug Control: Új pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet.
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• drug control: Új pszichoaktív anyag / New psychoactive substance (Hungary), 78/2022. (XII. 28.) BM rendelet
• color: white
• solubility: DMSO: soluble ~14 mg/mL
• storage temp.: 2-8°C
• SMILES string: NC(=O)c1cccc(c1)-c2cccc(OC(=O)NC3CCCCC3)c2
• InChI: 1S/C20H22N2O3/c21-19(23)16-8-4-6-14(12-16)15-7-5-11-18(13-15)25-20(24)22-17-9-2-1-3-10-17/h4-8,11-13,17H,1-3,9-10H2,(H2,21,23)(H,22,24)
• InChI key: ROFVXGGUISEHAM-UHFFFAOYSA-N

Descripción

General description

URB597 binds to active sites of fatty acid amide hydrolases and inhibits their activity. URB597 alters expression of tyrosine hydroxylase and interacts with abnormal-cannabidiol (Abn-CBD) and peroxisome proliferator-activated receptors (PPARs). URB597 elicits antinociception property via cannabinoid receptor by maintaining endocannabinoid anandamide (AEA) levels. URB597 reduces abnormal hyperactivity in neurons and could be for treatment of seizures and improving synaptic plasticity.

Biochem/physiol Actions

Potent, selective fatty acid amide hydrolase (FAAH) inhibitor.

Preparation Note

URB597 is soluble in DMSO at a concentration that is approximately 14 mg/ml.

Información de seguridad

• Clase de almacenamiento: 11 - Combustible Solids
• wgk: WGK 3
• ppe: Eyeshields, Gloves